Sanofi-Aventis News
Most Popular Sanofi-Aventis Story
Sanofi offers promising survival data on prostate cancer drug
Sanofi-Aventis has pulled the curtain back on a slate of promising, late-stage data for its prostate cancer drug cabazitaxel, demonstrating that the therapy prolongs the life of men with advanced... Read more...
Latest Headlines
- February 18, 2010
- February 10, 2010
- February 1, 2010
- January 11, 2010
- December 23, 2009
- December 17, 2009
- December 10, 2009
- December 9, 2009
- December 9, 2009
- December 1, 2009
- November 11, 2009
- October 29, 2009
- October 21, 2009
- October 13, 2009
- October 1, 2009
- September 30, 2009
- September 14, 2009
- August 31, 2009
- August 7, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
